Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients

NCT05013034 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV-2 Acute Respiratory Disease
SARS-CoV2 Infection
Cytokine Storm

Interventions

DRUG: Basiliximab Injection
DRUG: Placebo

Sponsor

Fort Worth Clinical Sciences Working Group

Collaborators

[object Object]